Noreen Walsh integrates clinical expertise with empathic presence, creating trust and psychological safety for patients ...

Diagnosed with limited-stage small-cell lung cancer, Tammy shares how treatment progress and a mindset shift helped her find hope.

Diagnosed with stage 1 lung cancer at 40, Gillian Ryan shares the overwhelming guilt she felt about bringing cancer into her family’s life. When Gillian Ryan was diagnosed with stage 1 non-small cell ...

Accelerated approval targets a post–PD-1-refractory population with limited established options, encompassing unresectable advanced cutaneous melanoma after progression on prior PD-1–based therapy.

Two breast cancer episodes over 15 years constrained broader life activities, underscoring how prolonged survivorship can narrow time, finances, and psychological reserve beyond direct medical demands ...

In this installment of the balance exercise series, physical therapist Leslie Waltke walks us through a move called the ...

Advisory committee deliberations focused on causal attribution in a single-arm study and whether clinical benefit can be distinguished from nivolumab effect, despite favorable response durability ...

In an interview with CURE, Dr. Mark Zhao, a colorectal surgeon at UCSF Health specializing in colorectal cancer and pelvic floor disorders, discussed transanal minimally invasive surgery, the single ...

Luciana Lopes Manfredini, BSN, PhD, of Einstein Hospital Israelita in São Paulo, Brazil, developed a triage scale for ...

Follicular lymphoma survivorship carries enduring relapse vigilance; “risk drops” does not equate to baseline risk restoration even years after completing therapy. Small interval decreases in ...

Cancer treatment has evolved over the past 20 years, but has the way it is depicted in television and movies also changed? The past 20 years have brought great advancements to cancer treatments, and ...

Megan Vered | Authors | CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.